Wells Fargo & Company Prime Medicine, Inc. Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

A detailed history of Wells Fargo & Company transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 20,358 shares of PRME stock, worth $76,342. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,358
Previous 11,810 72.38%
Holding current value
$76,342
Previous $82,000 26.83%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$4.3 - $8.03 $36,756 - $68,640
8,548 Added 72.38%
20,358 $104,000
Q1 2024

May 10, 2024
BUY
$6.35 - $9.39 $10,039 - $14,845
1,581 Added 15.46%
11,810 $82,000
Q4 2023

Feb 09, 2024
SELL
$5.59 - $9.55 $117,881 - $201,390
-21,088 Reduced 67.34%
10,229 $90,000
Q3 2023

Nov 13, 2023
BUY
$9.5 - $15.07 $142,690 - $226,351
15,020 Added 92.16%
31,317 $298,000
Q2 2023

Aug 15, 2023
BUY
$11.41 - $17.05 $163,859 - $244,855
14,361 Added 741.79%
16,297 $238,000
Q1 2023

May 12, 2023
BUY
$11.21 - $21.11 $21,702 - $40,868
1,936 New
1,936 $23,000

Others Institutions Holding PRME

# of Institutions
126
Shares Held
64.7M
Call Options Held
127K
Put Options Held
51.3K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $359M
More about PRME
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email